Inogen, Inc. (INGN)

NASDAQ: INGN · IEX Real-Time Price · USD
23.00
+0.11 (0.48%)
At close: Dec 2, 2022 4:00 PM
22.80
-0.20 (-0.87%)
After-hours: Dec 2, 2022 4:17 PM EST
0.48%
Market Cap 524.66M
Revenue (ttm) 365.55M
Net Income (ttm) -50.04M
Shares Out 22.88M
EPS (ttm) -0.88
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 222,750
Open 22.41
Previous Close 22.89
Day's Range 22.08 - 23.16
52-Week Range 19.48 - 36.3
Beta 0.96
Analysts Buy
Price Target 27.88 (+21.2%)
Earnings Date Nov 2, 2022

About INGN

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrat... [Read more]

Industry Health Care Equipment & Supplies
IPO Date Feb 14, 2014
CEO Scott Wilkinson
Employees 1,021
Stock Exchange NASDAQ
Ticker Symbol INGN
Full Company Profile

Financial Performance

In 2021, Inogen's revenue was $358.00 million, an increase of 16.05% compared to the previous year's $308.49 million. Losses were -$6.33 million, 8.65% more than in 2020.

Financial Statements

Analyst Forecast

According to 11 analysts, the average rating for INGN stock is "Buy." The 12-month stock price forecast is 27.88, which is an increase of 21.22% from the latest price.

Price Target
$27.88
(21.22% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Inogen to Present at Upcoming Investor Conferences in November 2022

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that management will present at the following investor...

4 weeks ago - Business Wire

Inogen (INGN) Q3 Earnings and Revenues Beat Estimates

Inogen's (INGN) third-quarter results benefit from higher revenues in its domestic business-to-business sales channel.

1 month ago - Zacks Investment Research

Inogen (INGN) Reports Q3 Loss, Tops Revenue Estimates

Inogen (INGN) delivered earnings and revenue surprises of 56.10% and 8.02%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

Inogen Announces Third Quarter 2022 Financial Results

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the quarter ended September 30, ...

1 month ago - Business Wire

Earnings Preview: Inogen (INGN) Q3 Earnings Expected to Decline

Inogen (INGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 month ago - Zacks Investment Research

3 Reasons to Add Inogen (INGN) Stock to Your Portfolio Now

Investors continue to be optimistic about Inogen (INGN) on its potential in the POC space and a strong product portfolio.

1 month ago - Zacks Investment Research

Inogen to Announce Third Quarter 2022 Financial Results on November 2, 2022

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will issue third qu...

1 month ago - Business Wire

3 Reasons to Hold Inogen (INGN) Stock in Your Portfolio

Investors continue to be optimistic about Inogen (INGN) on its potential in the POC space and a strong product portfolio.

2 months ago - Zacks Investment Research

Inogen (INGN) Q2 Earnings and Revenues Beat Estimates

Inogen's (INGN) second-quarter results benefit from higher revenues in its international business-to-business sales channel.

3 months ago - Zacks Investment Research

Inogen (INGN) Reports Q2 Loss, Tops Revenue Estimates

Inogen (INGN) delivered earnings and revenue surprises of 95% and 2.62%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

3 months ago - Zacks Investment Research

Inogen Announces Second Quarter 2022 Financial Results

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for...

3 months ago - Business Wire

Inogen (INGN) Surges 5.1%: Is This an Indication of Further Gains?

Inogen (INGN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the...

4 months ago - Zacks Investment Research

Earnings Preview: Inogen (INGN) Q2 Earnings Expected to Decline

Inogen (INGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

4 months ago - Zacks Investment Research

Inogen to Announce Second Quarter 2022 Financial Results on August 4, 2022

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release second...

4 months ago - Business Wire

Here's Why You Should Hold on to Inogen (INGN) Stock For Now

Investors continue to be optimistic about Inogen (INGN) on its potential in the POC space and a strong product portfolio.

5 months ago - Zacks Investment Research

Inogen Names Agnes Lee as Senior Vice President of Investor Relations and Strategic Planning

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Ag...

6 months ago - Business Wire

Inogen (INGN) Stock Inches Up 0.5% Post Q1 Earnings Beat

Inogen's (INGN) first-quarter results benefit from higher revenues across the majority of its geographical segments and categories.

6 months ago - Zacks Investment Research

Inogen (INGN) Reports Q1 Loss, Tops Revenue Estimates

Inogen (INGN) delivered earnings and revenue surprises of 20.83% and 5.09%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

6 months ago - Zacks Investment Research

Inogen Announces First Quarter 2022 Financial Results

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results for ...

6 months ago - Business Wire

Sommetrics Provides Update on the Pivotal SUPRA Clinical Trial for Sleep Apnea and Recent Corporate Accomplishments

VISTA, Calif.--(BUSINESS WIRE)--Sommetrics, a private company developing products and services to improve sleep health, today released an update on its key accomplishments during the first quarter of 20...

7 months ago - Business Wire

Inogen to Announce First Quarter 2022 Financial Results on May 5, 2022

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release first ...

7 months ago - Business Wire

Inogen Announces Participation in the 21st Annual Needham Virtual Healthcare Conference

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company's ma...

8 months ago - Business Wire

Here's Why You Should Hold on to Inogen (INGN) Stock Now

Inogen (INGN) continues to benefit from strength in the direct-to-customer business model. However, rising costs remain a woe.

8 months ago - Zacks Investment Research

Inogen Announces Board of Director Changes

GOLETA, California--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment o...

8 months ago - Business Wire

Inogen Announces Participation in the KeyBanc Life Sciences & MedTech Investor Forum

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company's ma...

8 months ago - Business Wire